Sign in

NCT06819046Completed

Improved Efficacy of Selective Laser Trabeculoplasty With the Addition of Rocklatan Post-treatment vs Artificial Tears Post-treatment

Source: ClinicalTrials.gov · Last updated 18 Mar 2026

Brief summary (registry, in English)

A randomized, single-site, parallel-group, prospective study of patients who are candidates for SLT, to study the effect of IOP change with Rocklatan vs artificial tears.

Status (registry)
Completed
Study type
Observational
Enrollment
70 (actual)
First submitted
6 Feb 2025
Start date
14 Feb 2025
Primary completion date
17 Dec 2025
Lead sponsor
Colorado Ophthalmology Associates PC
Diseases
Glaucoma
NCT number
NCT06819046

What you commit to

  • Study type: Observational
  • Participants enrolled: 70
  • From 14 Feb 2025 to the primary completion date, 17 Dec 2025
  • 1 site in 1 country
  • Visits and tests: ask the trial team, the registry does not list them

Built from the registry fields of ClinicalTrials.gov. It describes the study, not your situation.

Who cannot take part

Copied verbatim from ClinicalTrials.gov and grouped by topic. Only the trial team decides who can take part.

Prior treatment

  • Prior use of rho kinase inhibitor
  • Previous SLT performed on either eye
  • Prior MIGS implanted in either eye
  • Prior or current intolerance of a Rho kinase inhibitor
  • Uncontrolled IOP on maximum tolerated medical therapy; unable to washout
  • Anticipated use of intra-ocular or topical steroids not associated with the study protocol
  • Current participation of study drugs or devices or within 6 months prior to screening

Other illness

  • Medication conditions that prevent SLT
  • History of corneal disease or dystrophy, including endothelial dysfunction
  • History of corneal edema
  • Current or history of intra-ocular infection or inflammation
  • History of retinal diseases that will could affect diagnostic testing
  • Any condition in the opinion in the investigator that would potentially confound the results of this study

Other

  • Patients MD \<-12, HVF defects in both hemispheres or involving fixation
  • Narrow angles or other angle abnormalities
  • Pregnant or planning to be pregnant throughout the study

Who the study is looking for

  • Patients 18 years and older
  • Documented diagnosis of mild to moderate primary open angle glaucoma or ocular hypertension. Diagnosis of primary open angle glaucoma must be supported by the following:
    • 24-2 SITA faster within the last 6 months
    • \- With a mean deviation of 0 to -12 dB, excluding patients that meet severe criteria by having defects involving fixation or in two hemispheres.
    • OCT RNFL and optic nerve examination within the last 6 months
    • Diffuse or focal narrowing or notching of the optic disc rim, progressive narrowing of the neuroretinal rim, diffuse or localized thinning of the parapapillary RNFL, optic disc asymmetry of the two eyes consistent with loss of neural tissue, or thinning of the RNFL/GCA on examination or imaging
    • Progressive thinning on SD-OCT of 7 microns in inferior and superior quadrants or \>4 micron loss in global RNFL thickness
    • Deviation from this ISNT rule (inferior, superior, nasal and temporal order of RNFL thickness with the inferior RNFL quadrant being the thickness)
  • Candidate for bilateral SLT
  • Post-washout, post-SLT IOPs between 28-10
  • Gonioscopy findings of Schafer grade III and IV

Age in the registry: 18 years to - · Sex: All

Full criteria on ClinicalTrials.gov

Sites (1)

Sites in registry order. Pick your city on the disease page to sort them by distance.

SiteCityCountrySite status
Colorado Ophthalmology Associates PC
Coordinator of this site? Confirm its status
DenverUnited StatesUnknown status

This page is information, not medical advice. Discuss any trial with your doctor.